NADJA SCHWARZ advises on all aspects of German business and corporate law, with a particular focus on life sciences and domestic and cross-border mergers and acquisitions. Her practice combines EU and German regulatory, compliance, and private equity/M&A knowledge. Nadja’s clients include domestic and international private equity funds, asset managers, strategic investors, pharmaceutical, biotechnology, medical device, food, cosmetic, and other consumer goods companies.